Caisse DE Depot ET Placement DU Quebec trimmed its holdings in shares of Stryker Corporation (NYSE:SYK) by 37.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,829 shares of the medical technology company’s stock after selling 16,400 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in Stryker were worth $3,826,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Koch Industries Inc. boosted its position in shares of Stryker by 34,120.3% in the second quarter. Koch Industries Inc. now owns 1,260,675 shares of the medical technology company’s stock worth $1,252,000 after purchasing an additional 1,256,991 shares during the period. BlackRock Inc. boosted its position in shares of Stryker by 5.2% in the second quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock worth $3,208,017,000 after purchasing an additional 1,139,082 shares during the period. Janus Henderson Group PLC boosted its position in shares of Stryker by 2,237.8% in the second quarter. Janus Henderson Group PLC now owns 1,019,254 shares of the medical technology company’s stock worth $141,452,000 after purchasing an additional 975,656 shares during the period. Vanguard Group Inc. boosted its position in shares of Stryker by 2.8% in the second quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock worth $3,341,643,000 after purchasing an additional 657,656 shares during the period. Finally, APG Asset Management N.V. boosted its position in shares of Stryker by 117.1% in the third quarter. APG Asset Management N.V. now owns 583,736 shares of the medical technology company’s stock worth $82,902,000 after purchasing an additional 314,800 shares during the period. Institutional investors own 74.97% of the company’s stock.

In other news, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the sale, the insider now owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 7.40% of the stock is owned by corporate insiders.

A number of equities analysts have weighed in on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Stryker in a research report on Thursday. ValuEngine lowered shares of Stryker from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Robert W. Baird upgraded shares of Stryker from a “neutral” rating to an “outperform” rating in a research report on Friday, November 24th. SunTrust Banks restated a “buy” rating and set a $161.00 target price on shares of Stryker in a research report on Friday, November 17th. Finally, Oppenheimer set a $156.00 target price on shares of Stryker and gave the stock a “hold” rating in a research report on Monday, October 30th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and thirteen have issued a buy rating to the company’s stock. Stryker has an average rating of “Hold” and a consensus price target of $152.10.

Stryker Corporation (NYSE:SYK) traded up $0.78 during trading on Monday, reaching $151.93. 688,000 shares of the company were exchanged, compared to its average volume of 1,178,901. The stock has a market capitalization of $56,857.92, a P/E ratio of 24.08, a price-to-earnings-growth ratio of 2.39 and a beta of 0.78. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. Stryker Corporation has a 52 week low of $115.75 and a 52 week high of $160.62.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.50 by $0.02. The company had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.97 billion. Stryker had a net margin of 14.67% and a return on equity of 24.11%. Stryker’s revenue was up 6.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.39 earnings per share. sell-side analysts anticipate that Stryker Corporation will post 6.47 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be paid a dividend of $0.47 per share. This is an increase from Stryker’s previous quarterly dividend of $0.43. The ex-dividend date is Thursday, December 28th. This represents a $1.88 dividend on an annualized basis and a yield of 1.24%. Stryker’s dividend payout ratio is presently 36.32%.

TRADEMARK VIOLATION WARNING: “Caisse DE Depot ET Placement DU Quebec Sells 16,400 Shares of Stryker Corporation (SYK)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/12/11/caisse-de-depot-et-placement-du-quebec-sells-16400-shares-of-stryker-corporation-syk.html.

Stryker Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.